| Literature DB >> 18727816 |
Malte Ludwig1, Tomasz Zielinski, Dieter Schremmer, Klaus O Stumpe.
Abstract
BACKGROUND: Non-invasive 3-dimensional (3D) ultrasound (US) has emerged as the predominant approach for evaluating the progression of carotid atherosclerosis and its response to treatment. The aim of this study was to investigate the quality of a central reading procedure concerning plaque volume (PV), measured by 3D US in a multinational US trial.Entities:
Mesh:
Year: 2008 PMID: 18727816 PMCID: PMC2531085 DOI: 10.1186/1476-7120-6-42
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Figure 1Carotid plaque images obtained with 3D US. The plaque is presented in longitudinal and cross-sectional views. The 3D image has been sliced 6 times from one end to the other along the vessel axis in the scan direction.
Inter- and intra-reader variabilities for re-reading plaque volume (PV) of 45 plaques
| PV reading 1 (μl) | 71.8 (42.5) | 67.8 (42.8) | 70.1 (45.4) |
| PV reading 2 (μl) | 71.6 (43.3) | 70.0 (43.0) | 71.5 (44.0) |
| ICC | 0.985 | 0.967 | 0.969 |
| PV both readings (μl) | 71.7 (42.7) | 68.9 (42.2) | 70.8 (44.4) |
| ICC | 0.964 | ||
Values are mean (standard deviation); ICC, intra-class correlation coefficient
Intra-class correlation coefficients for re-reading plaque volume (PV) of 21 plaques with PV < 60 μl and 24 plaques with PV ≥ 60 μl
| 0.929 | 0.783 | 0.689 | |
| 0.805 | |||
| 0.976 | 0.960 | 0.960 | |
| 0.949 | |||
Coefficients of variation (CV) and repeatability coefficients (RC) for 60 plaques comparing the 5S- and 10S- methods
| 30 | 4.3 (2.0) | 3.8 (1.9) | 3.9 | |
| 30 | 2.4 (1.1) | 2.4 (0.9) | 5.3 | |
| 60 | 3.4 (1.9) | 3.1 (1.6) | 4.7 | |
PV, plaque volume
CV was calculated from 3 individual measurements, values are mean (standard deviation)
RC was calculated for mean of 3 individual measurements comparing 5S and 10S
Figure 2Difference against average of PV measurements using the 5S- and 10S-methods (second data set, n = 60).
Figure 3Carotid plaque images obtained with 3D US showing an example of plaque regression under therapy with a daily dose of 40 mg olmesartan: a) A fibrous non-calcified plaque of the carotid artery (bulb) presented in longitudinal and cross sectional views at the start of therapy (Mean volume: 384 μL). b) The same plaque during therapy six months later (Mean volume: 250 μL). c) The same plaque (no longer visible) 16 months later.